MEDCOR
ActiveMEDCOR has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €145k and a net result of €124k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 22% of 37959 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2024
70
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability93▼-7
Solvency48▲+20
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10k at 30 days acceptable
Liquidity ample (current ratio 6.24 against 2.34 in 2023; short-term debt: 14.4% and cash: 11% of total assets), but 77.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 37959 sector peers (2024).
NBB · sector comparisonPosition among 37959 sector peers
Solvency
better than 22%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
76 d early
2022
31 d late
2021
31 d late
2020
27 d late
2019
33 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€145k▲ 606%
2023 · €20k
2019: €19k
2020: €108k
2021: €260k
2022: €365k
2023: €20k
2019 → 2024
Total assets
€637k▼ 14.7%
2023 · €747k
2019: €552k
2020: €691k
2021: €818k
2022: €968k
2023: €747k
2019 → 2024
Net result
€124k▼ 37.8%
2023 · €200k
2019: €6k
2020: €144k
2021: €161k
2022: €118k
2023: €200k
2019 → 2024
Working capital
€482k▲ 28.3%
2023 · €376k
2019: €64k
2020: €132k
2021: €271k
2022: €426k
2023: €376k
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€108k-€260k▲ 142%€365k▲ 40.4%€20k▼ 94.4%€145k▲ 606%
Operating result€187k-€220k▲ 17.3%€156k▼ 29.1%€268k▲ 72.2%€159k▼ 40.9%
Net result€144k-€161k▲ 11.7%€118k▼ 26.4%€200k▲ 68.9%€124k▼ 37.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 41% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €637k
Fixed assets
€63k▼ 30.1%
Current assets
€574k▼ 12.6%
Equity and liabilities €637k
Equity
€145k▲ 606%
Debt
€492k▼ 32.2%
The debt ratio falls from 97.3% to 77.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€188k▼
2023 · €298k
Cash flow
€154k▼
2023 · €229k
Solvency
22.7%▲
2023 · 2.7%
Current ratio
6.24▲
2023 · 2.34
Quick ratio
6.24▲
2023 · 2.34
Debt / equity
3.40▼
2023 · 35.50
ROE
85.8%▼
2023 · 975.7%
ROA
19.5%▼
2023 · 26.7%
Interest coverage
19.30▼
2023 · 23.20
Debt
€492k▼
2023 · €726k
Debt ≤ 1 year
€92k▼
2023 · €281k
Debt > 1 year
€400k▼
2023 · €445k
Income taxes
€38k▼
2023 · €64k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€747k€637k▼
Fixed assets21/28€90k€63k▼
Tangible fixed assets22/27€90k€63k▼
Plant, machinery and equipment23€1k€3k▲
Furniture and vehicles24€89k€60k▼
Current assets29/58€657k€574k▼
Amounts receivable within one year40/41€50k€54k▲
Trade receivables40€50k€50k▼
Other amounts receivable41€30€4k▲
Current investments50/53-€450k
Cash at bank and in hand54/58€606k€70k▼
Equity and liabilities
Total equity and liabilities10/49€747k€637k▼
Equity10/15€20k€145k▲
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Profit (loss) carried forward14-€124k
Amounts payable17/49€726k€492k▼
Amounts payable after more than one year17€445k€400k▼
Financial debts170/4€445k€400k▼
Amounts payable within one year42/48€281k€92k▼
Current portion of amounts payable after more than one year42€44k€45k▲
Trade debts44€14€564▲
Suppliers440/4€14€564▲
Taxes, remuneration and social security45€79k€46k▼
Taxes450/3€79k€46k▼
Other amounts payable47/48€159k€491▼
Income statement
Code20232024
Non-recurring operating income76A€7k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29k€30k▲
Other operating charges640/8€4k€1k▼
Non-recurring operating charges66A€856-
Gross operating margin9900€303k€189k▼
Operating profit (loss)9901€268k€159k▼
Financial income75/76B€8k€14k▲
Recurring financial income75€8k€14k▲
Financial charges65/66B€13k€10k▼
Recurring financial charges65€13k€10k▼
Profit (loss) for the period before taxes9903€264k€163k▼
Income taxes67/77€64k€38k▼
Profit (loss) for the period9904€200k€124k▼
Profit (loss) for the period to be appropriated9905€200k€124k▼
Appropriation of the result
Profit (loss) to be appropriated9906€544k€124k▼
Profit (loss) brought forward from the previous period14P€345k-
Profit to be distributed694/7€544k-
Return on contributions (dividend)694€544k-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Liquidity triplescurrent ratio 6.24
Current ratio from 2.34 to 6.24; short-term debt falls from €281k to €92k.
31-12
Financial
Equity above €100kEq €145k ▲606%
6 profitable years in a row build equity to €145k.
16-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2019net €200k ▲68.9%
Operating result €268k, net result €200k, both a record.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Equity above €200kEq €260k ▲142%
3 profitable years in a row build equity to €260k.
27-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 27 days late
2020
31-12
Financial
Equity above €100kEq €108k ▲474%
2 profitable years in a row build equity to €108k.
02-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 33 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Destelbergen · 2 establishment units since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hooiwegel(HEU) 149070 DestelbergenGround area
5,269 m²
Building footprint
215 m²
Volume, LiDAR
1,285 m³
2 parcels, Flanders · tallest building 9.4 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
MEDCOR
since 20182.288.231.285
Medcor
since 20242.359.457.296
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44028A0645/00A002 | Flanders | 4,942 m² | 1 · 126 m² | 9.4 m · 2 fl. |
| 44013B0617/00C000 | Flanders | 327 m² | 1 · 89 m² | 7.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
875500BZXXC58GJIXO25
Similar companies · same sector, comparable size
CYC2
BE 0807.267.751
Lasne · Eq €145k
ANSOLO
BE 0767.477.658
Schoten · Eq €145k
Dots Energy
BE 0799.161.323
Zonhoven · Eq €145k
FVDB CONSULT
BE 0670.622.762
Kontich · Eq €145k
REALAB
BE 0729.545.809
Brussel · Eq €145k
Of 82,569 companies in sector 70200 we hold annual accounts for 52,577. 40,852 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded24-10-2018
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
68310Real estate agency activities
68311Real estate activities
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.